Nissay Asset Management Corp Japan Acquires 6,586 Shares of Welltower Inc. $WELL

Nissay Asset Management Corp Japan grew its holdings in shares of Welltower Inc. (NYSE:WELL) by 3.3% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 205,356 shares of the real estate investment trust’s stock after buying an additional 6,586 shares during the period. Nissay Asset Management Corp Japan’s holdings in Welltower were worth $46,610,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. BlackRock Inc. increased its position in Welltower by 5.5% during the 2nd quarter. BlackRock Inc. now owns 78,049,214 shares of the real estate investment trust’s stock valued at $17,714,830,000 after purchasing an additional 4,045,458 shares during the period. Capital International Investors lifted its position in shares of Welltower by 2.0% in the 4th quarter. Capital International Investors now owns 47,431,769 shares of the real estate investment trust’s stock worth $8,805,411,000 after purchasing an additional 915,514 shares during the period. State Street Corp lifted its position in shares of Welltower by 1.2% in the 4th quarter. State Street Corp now owns 41,760,328 shares of the real estate investment trust’s stock worth $7,751,134,000 after purchasing an additional 506,374 shares during the period. Norges Bank bought a new stake in shares of Welltower during the 4th quarter valued at about $5,466,264,000. Finally, Bank of America Corp DE boosted its stake in shares of Welltower by 6.6% during the 1st quarter. Bank of America Corp DE now owns 21,750,501 shares of the real estate investment trust’s stock valued at $4,300,291,000 after purchasing an additional 1,347,243 shares in the last quarter. 94.80% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Welltower news, Director Andrew Gundlach bought 5,000 shares of the stock in a transaction dated Tuesday, August 25th. The stock was purchased at an average cost of $239.47 per share, for a total transaction of $1,197,350.00. Following the completion of the acquisition, the director owned 25,000 shares of the company’s stock, valued at approximately $5,986,750. This trade represents a 25.00% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.37% of the company’s stock.

Welltower Stock Down 0.9%

NYSE:WELL opened at $237.51 on Friday. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.16 and a quick ratio of 3.16. The firm’s 50-day moving average price is $235.54 and its 200-day moving average price is $217.59. The company has a market capitalization of $171.18 billion, a PE ratio of 108.95, a P/E/G ratio of 1.15 and a beta of 0.76. Welltower Inc. has a 1-year low of $163.75 and a 1-year high of $255.20.

Welltower (NYSE:WELL) last issued its quarterly earnings results on Monday, July 27th. The real estate investment trust reported $0.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.66 by ($0.05). Welltower had a net margin of 12.15% and a return on equity of 3.56%. The business had revenue of $3.54 billion for the quarter, compared to analysts’ expectations of $3.40 billion. During the same period last year, the business earned $1.28 earnings per share. The company’s revenue was up 39.1% on a year-over-year basis. Welltower has set its FY 2026 guidance at 6.360-6.440 EPS. On average, equities analysts predict that Welltower Inc. will post 6.43 EPS for the current fiscal year.

Welltower Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 20th. Shareholders of record on Wednesday, August 12th were paid a dividend of $0.85 per share. This is a positive change from Welltower’s previous quarterly dividend of $0.74. This represents a $3.40 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend was Wednesday, August 12th. Welltower’s payout ratio is 155.96%.

Analyst Ratings Changes

Several equities analysts recently issued reports on the stock. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Welltower from $215.00 to $265.00 and gave the company a “buy” rating in a research report on Wednesday, July 1st. Citigroup lifted their price objective on Welltower from $255.00 to $275.00 and gave the company a “buy” rating in a research report on Friday, July 31st. Raymond James Financial started coverage on Welltower in a report on Tuesday, June 16th. They set an “outperform” rating and a $226.00 target price on the stock. Royal Bank Of Canada upped their target price on Welltower from $238.00 to $260.00 and gave the stock an “outperform” rating in a report on Monday, August 3rd. Finally, Barclays assumed coverage on Welltower in a research report on Tuesday, July 7th. They issued an “equal weight” rating and a $254.00 target price for the company. Fourteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $246.11.

About Welltower

Welltower Inc (NYSE: WELL) is a real estate investment trust (REIT) that acquires and manages real estate serving the health care industry. The company specializes in healthcare infrastructure, owning and operating a diversified portfolio of senior housing, post-acute and long-term care communities, and outpatient medical properties. Welltower’s assets are designed to support the delivery of health care services through a combination of leased properties, joint ventures, and other capital arrangements with health care operators and providers.

The company’s property types include assisted living, memory care, independent living and skilled nursing facilities, as well as medical office buildings and other outpatient-care real estate such as ambulatory surgery centers and specialty clinics.